DIFLUPREDNATE

Product NDC
69315-329
11-digit product format
693150329
Labeler code
69315
Product ID
69315-329_3dd0b742-d0d7-4922-8c9d-01293432b710
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
DIFLUPREDNATE
Dosage form
EMULSION
Route
OPHTHALMIC
Labeler
Leading Pharma, LLC
Application
ANDA219441
Marketing category
ANDA
Marketing start
2025-02-18
Substance
DIFLUPREDNATE
Active strength
.5 mg/mL
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A219441-001DIFLUPREDNATEDIFLUPREDNATE0.05%EMULSION / OPHTHALMICAB2024-12-13

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A219441-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A219441-001DIFLUPREDNATE0.05%EMULSION / OPHTHALMICAB2024-12-1384e616aacf4f…
2026-08-18 06:07:402026-07A219441-001DIFLUPREDNATE0.05%EMULSION / OPHTHALMICAB2024-12-13caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A219441-001DIFLUPREDNATE0.05%EMULSION / OPHTHALMICAB2024-12-13011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A219441-001DIFLUPREDNATE0.05%EMULSION / OPHTHALMICAB2024-12-1331067a03dcf5…
2025-08-23 18:47 UTC2025-08A219441-001DIFLUPREDNATE0.05%EMULSION / OPHTHALMICAB2024-12-136a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A219441-001DIFLUPREDNATE0.05%EMULSION / OPHTHALMICAB2024-12-13fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A219441-001DIFLUPREDNATE0.05%EMULSION / OPHTHALMICAB2024-12-13b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A219441-001DIFLUPREDNATE0.05%EMULSION / OPHTHALMICAB2024-12-1303ed91905a0d…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219441-001DIFLUPREDNATE0.05%EMULSION / OPHTHALMICAB2024-12-13a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08A219441-001AB184e616aacf4f…
2026-08-18 06:07:402026-07A219441-001AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A219441-001AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A219441-001AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A219441-001AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A219441-001AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A219441-001AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A219441-001AB103ed91905a0d…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219441-001AB1a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
DIFLUPREDNATE
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
DIFLUPREDNATE.5 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
S8A06QG2QEInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
804544Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
054ca798-454a-41cc-9d08-97bb8bef5620Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
05bd5167-c8bb-b60b-f647-c2bfd6944eb3Product name520260107
6bd95106-a412-1dad-b9cc-4cb74bfb27ceProduct name220230315
3c386306-c48a-413e-bb69-70cb268496f3Product name120210727
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
290f523a-f9db-9774-b5a9-e1f908ac1782Product name120150828
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324
c6b65c52-69c7-df49-550a-a50c137f6218Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
69315-329-05DIFLUPREDNATE5 mL in 1 BOTTLEEMULSION51
69315-329-05DIFLUPREDNATE1 in 1 CARTONEMULSION11

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
69315-329-05ML - Milliliter69315-3292a72ad09-39b0-4bdb-a33e-17fb8f1ca69412025-03-04

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
69315-329DIFLUPREDNATE EMULSION [LEADING PHARMA, LLC]1Current NDC, 2 package rows20250221_054ca798-454a-41cc-9d08-97bb8bef5620.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DIFLUPREDNATEDIFLUPREDNATELeading Pharma, LLC054ca798-454a-41cc-9d08-97bb8bef56202025-02-08Warnings, Adverse reactionsExact identifier
application applno (ANDA): 219441
application number: ANDA219441
ndc (product): 69315-329
DifluprednateDIFLUPREDNATECaplin Steriles Limited0f9a1987-6a04-4764-94e5-7053997c058b2024-12-26Warnings, Adverse reactionsExact identifier
application applno (ANDA): 219441
application number: ANDA219441

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
804544difluprednate 0.05 % Ophthalmic EmulsionPSN054ca798-454a-41cc-9d08-97bb8bef56201
804544difluprednate 0.5 MG/ML Ophthalmic SuspensionSCD054ca798-454a-41cc-9d08-97bb8bef56201
804544difluprednate 0.05 % Ophthalmic EmulsionSY054ca798-454a-41cc-9d08-97bb8bef56201

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
69315-329-05693150329051 BOTTLE in 1 CARTON (69315-329-05) / 5 mL in 1 BOTTLE1 bottle2025-02-18NoNoCurrent